ALTSTATION.IO

Marsh & McLennan Companies, Inc. (MMC) Stock Analysis

By Nova Skye | AltStation.io | Updated February 07, 2026

Price

$182.70

Change

0.00%

Market Cap

$89.82B

Avg Volume

2.7M

Company Overview

Marsh & McLennan Companies, Inc. (MMC) is a professional services firm headquartered in New York. It caters to clients globally by offering advisory services and insurance solutions primarily focused on risk management, strategy, and human capital. Their services include risk assessment, insurance broking, and consulting on health, wealth, and careers. MMC serves a diverse clientele that ranges from businesses and public entities to insurance companies and private clients.

MMC is a market leader in the insurance brokerage and consulting sectors, benefiting from a strong reputation and extensive experience since 1871. Their breadth of services and global reach give them a significant competitive advantage. Key competitors include Aon plc, Willis Towers Watson, and Gallagher. However, they face threats from evolving regulations, technological disruption, and shifting customer expectations as the financial services landscape becomes increasingly competitive.

Currently, MMC is on a growth trajectory, bolstered by strategic acquisitions and expanding service offerings. Recent milestones include the acquisition of several firms to enhance their consulting capabilities and the continued investment in technology to improve client services. This strategic focus positions MMC well for future challenges and opportunities in the financial services sector.

Key Financials

Market Cap

$89.82B

Revenue

$26.45B

EBITDA

$7.73B

Gross Margin

44.0%

Profit Margin

15.6%

Revenue Growth

11.5%

Total Cash

$2.51B

Total Debt

$21.43B

Free Cash Flow

$4.72B

52-Week Price Performance Analysis

Price Statistics

P/E Ratio

21.93

Forward P/E

17.72

Beta

0.75

52-Week High

$248.00

52-Week Low

$174.18

EPS

$8.33

50-Day Avg

$183.73

200-Day Avg

$202.15

Price/Book

5.91

Technical Analysis

Over the 52-week period, Marsh & McLennan Companies, Inc. (MMC) exhibits a pronounced downtrend, having decreased approximately 17.5% from a peak around $240 in February to the current price of $182.70. The chart identifies a key resistance level near $185.03, which the stock has struggled to exceed recently, while strong support is indicated around $180. Notable patterns include lower highs from February to December, reinforcing the bearish sentiment. In the past few weeks, there has been a slight upward momentum, but it remains uncertain if this will sustain against the downward trend. The current price of $182.70 is just above the aforementioned support zone, suggesting a crucial test for continued viability; a drop below this level could trigger further declines. Overall, the position within the 52-week range reflects significant weakness and concerns about the stock’s future performance.

Recent News and Developments

Here are the latest news and developments for Marsh & McLennan Companies, Inc

(MMC) stock in the past week:

1. Marsh & McLennan Exceeds Q4 2025 Earnings and Revenue Expectations

Marsh & McLennan Companies (MRSH), the global professional services firm, announced its financial results for the fourth quarter of fiscal year 2025 on January 29, 2026. The company surpassed analysts’ estimates for both earnings per share and revenue. An earnings call transcript was also made available on the same day, detailing the company’s performance.

2. Positive Outlook for 2026 and Capital Deployment Plans

Following the strong Q4 2025 performance, Marsh & McLennan’s management provided a positive outlook for the upcoming fiscal year. They anticipate underlying revenue growth in 2026 to be similar to that of 2025, alongside continued margin expansion and solid adjusted earnings per share growth. The company plans to deploy approximately $5 billion of capital during 2026, which will be allocated across dividends, acquisitions, and share repurchases.

Market Sentiment and Analyst Recommendations

Bull Case

MMC just beat Q4 earnings and revenue expectations, which matters given the company’s size and analyst coverage. Management is guiding for similar underlying revenue growth in 2026 as 2025 hit (11.5%), with margin expansion and solid EPS growth expected. The $5 billion capital deployment plan signals confidence — that’s real money going back to shareholders through dividends, buybacks, and acquisitions. At 21.93x P/E, the stock trades in line with quality professional services firms, not at a premium. Most importantly, consensus price target sits at $216.88, implying 18.9% upside from current levels, and 21 analysts recommend buy. The stock is only 1.5% above key support at $180, meaning downside is defined while upside has room to run.

Bear Case

The technical picture is brutal. MMC has dropped 17.5% from its $240 peak in February, forming lower highs all year — that’s textbook weakness. The stock is fighting resistance at $185.03 and sitting right on support at $182.70, which means one bad earnings miss or macro headwind breaks the floor. Debt stands at $21.43B against just $2.51B in cash, giving the company limited flexibility if economic conditions deteriorate. The mixed analyst sentiment tells the real story: 10 of 18 recommend hold, and one sell. Even the bull case price target of $216.88 only gets you back to where the stock traded months ago — that’s not compelling upside for the risk. If the market reprices professional services lower or recession fears spike, this debt load becomes a real problem.

What to Watch

Monitor Q1 2026 earnings in April for evidence that the positive 2026 guidance holds up in reality, particularly underlying revenue growth rates and margin expansion. Watch the $185 resistance level closely — a sustained break above it would signal the downtrend is breaking and could trigger momentum buying toward $210-215. Track any M&A announcements from that $5 billion deployment plan; large acquisitions at inflated valuations could dilute shareholder returns. Keep an eye on interest rates and recession probability, since a 200+ basis point rate spike or inverted yield curve would immediately pressure the valuation multiple. The $180 support is critical — a close below that level on heavy volume suggests institutional selling and could accelerate declines toward $170. Finally, watch analyst estimate revisions in the coming weeks; if the beat triggers upward revisions to 2026 guidance, that’s a catalyst. If estimates stay flat or decline, the rally fades quickly.

Analyst Consensus

BUY

Based on 21 analyst opinions

Low Target

$174.00

Mean Target

$210.71

High Target

$258.00

Earnings and Financial Data

Sector

Financial Services

Industry

Insurance Brokers

Employees

90,000

Earnings & Dividends

Next Earnings

TBD

EPS (Trailing)

$8.33

Dividend Yield

2.0%

Payout Ratio

41.1%

Frequently Asked Questions

Is MMC a good stock to buy?

Yes, analysts recommend buying MMC stock with a target price of $210.71. With a P/E ratio of 21.93, it offers solid growth potential in the financial services sector.

What is MMC’s price target?

The current analyst consensus sets the price target for MMC at $210.71. This reflects a potential upside of about 15.3% from the current price of $182.70.

Does MMC pay a dividend?

Yes, Marsh & McLennan pays a dividend with a yield of 2.0%. This makes it attractive for income-focused investors in addition to its growth prospects.

What is MMC’s market capitalization?

MMC has a market capitalization of approximately $89.82 billion. This positions it as a major player in the insurance brokerage industry.

What has been MMC’s 52-week price range?

MMC has traded between $174.18 and $248.00 over the past year. This range highlights its volatility but also provides investors potential buying opportunities during dips.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated February 07, 2026.